Eledon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -14,108 | -39,025 | -10,331 | -17,459 |
EBIT | -10,412 | |||
Net Income | -31,630 | -39,025 | -10,447 | -17,459 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,677 | -22,612 | -14,091 | -14,477 |
Cash | 6,803 | 6,152 | 22,808 | 3,669 |
Basic Shares | 113,631 | 112,424 | 75,430 | 77,156 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -359 | -374 | -373 | |
EBITDA | -45,269 | -35,394 | -42,626 | -39,407 |
EBIT | -45,582 | -35,753 | -43,000 | -39,780 |
Net Income | -45,617 | -36,184 | -40,326 | -87,966 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -62,341 | -47,271 | -39,527 | -28,424 |
Cash | 22,808 | 20,549 | 4,612 | 56,409 |
Basic Shares | 81,836 | 48,543 | 24,619 | 14,285 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.19 |
2026-03-31 | -$0.33 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.21 |